Article

Diagnostic approach in allergic and irritant contact dermatitis.

Department of Dermatology, Republic University of Uruguay, Montevideo, Uruguay.
Expert Review of Clinical Immunology (Impact Factor: 3.34). 03/2010; 6(2):291-310. DOI: 10.1586/eci.10.4
Source: PubMed

ABSTRACT Contact dermatitis is a highly frequent disease with a significant impact on the quality of life of the affected patients and a relevant socioeconomic impact. According to the pathophysiological mechanisms involved, two major types of contact dermatitis may be recognized: irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD). The two types may, and often do, coexist. Differentiating between ICD and ACD is often difficult in the clinical setting. The basis for a diagnosis of either ICD or ACD is mainly established by a comprehensive clinical history and physical examination, as well as by performing appropriate diagnostic patch testing. The only useful and reliable method for the diagnosis of ACD remains the patch test. Positive patch test results, the current and/or past relevance of which has to be assessed, are confirmative of contact sensitization. Additional tests, such as the repeated open application test or the provocative use test, are sometimes necessary to confirm a causal relationship. This algorithmic diagnostic approach will allow the adoption of rational measures of allergen or irritant avoidance and the implementation of realistic patient information and education.

2 Followers
  • [Show abstract] [Hide abstract]
    ABSTRACT: Allergic contact dermatitis (ACD) is triggered by an aberrant hyperinflammatory immune response to innocuous chemical compounds and ranks as the world's most prevalent occupational skin condition. Although a variety of immune effector cells are activated during ACD, regulatory T (Treg) cells are crucial in controlling the resulting inflammation. Insulin-like growth factor-1 (IGF-1) regulates cell proliferation and differentiation and accelerates wound healing and regeneration in several organs including the skin. Recently IGF-1 has also been implicated in protection from autoimmune inflammation by expansion of Treg cells. Here, we demonstrate that ectopic expression of IGF-1 in mouse skin suppresses ACD in a Treg cell-specific manner, increasing the number of Foxp3(+) Treg cells in the affected area and stimulating lymphocyte production of the anti-inflammatory cytokine interleukin 10. Similar therapeutic effects can be achieved with systemic or topical delivery of IGF-1, implicating this growth factor as a promising new therapeutic option for the treatment of ACD.
    Disease Models and Mechanisms 08/2014; 7(8):977-85. DOI:10.1242/dmm.015362 · 5.54 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Contact dermatitis (CD) is a common itchy inflammatory skin disease. It is the most common skin disease in industrialized societies. In a recent study the incidence rates of CD was found to be 13.4 % and the point prevalence was found as 20.1 % (Mortz, Bindslev-Jensen and Andersen Br, J Dermatol 2013;168(2):318–25). There are two main types of CD: irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD). Most cases are ICD (80 %). ICD is a non-immune non specific reaction caused by direct injury to the skin by strong irritants like: strong acids and alkalis. ACD is an immune mediated delayed type hypersensitivity reaction induced by many materials (allergens) like: metals, preservatives, perfumes, rubber, resins, dyes and many more. This type of CD appears only in patients that previously were sensitized to these materials (Ale and Maibacht, Expert Rev Clin Immunol 2010;6(2):291–310). Patch tests are used to identify the culprit allergens. In this article we will discuss the issues of contact dermatitis and patch testing in pregnancy.
    09/2014; 3(3). DOI:10.1007/s13671-014-0081-2
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: A pharmaco-chemical investigation of the Euphorbia cyparissias plant was justified by its known multiple therapeutic valences. Numerous components from extracts and latex of Euphorbiacae were identified, revealing a large plant family with a polyvalent therapeutic activity. Materials and Methods: The aim of the study was to assess the skin tolerance level to irritation on different testing concentrations, of Euphorbia cyparissias extracts and ointments. Study was accomplished in rats and dogs, with the identification of all possible skin injuries and histological changes, after a simple patch test methodology. Results: Ointment dermatological testing on rats, proved to be bearable on epilated skin at concentrations of 1, 2 and 5%. Ointments and mother tincture with higher concentrations (10% and 20%), led to irritation and cutis damages, and this was revealed through histology. Conclusion: Ointment tested on dog’s skin was tolerable for epilated skin to concentrations of 1, 2 and/or 5%, additional testing on human volunteers confirmed the same situation.
    African Journal of Traditional, Complementary and Alternative Medicines 04/2014; 11(3):1-6. DOI:10.4314/ajtcam.v11i3.1 · 0.56 Impact Factor